Zosano Pharma (ZSAN) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 65 254 sessions, June 10, 2021 to June 10, 2022
- Largest daily move
- -48.6% close of February 9, 2022
- 1-year change
- -98.3% closing prices, June 10, 2021 to June 10, 2022
- 5-year change
- -99.9% closing prices, June 9, 2017 to June 10, 2022
Company Description
Zosano Pharma (Nasdaq: ZSAN) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $2.7M.
ZSAN has declined 98.3% over the past year. The last closing price was $0.5576.
This page collects what Stock Titan holds for ZSAN, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Zosano Pharma (ZSAN) closed at $0.5576 on June 10, 2022. Over the past 12 months, the price has lost 98.3%.
ZSAN Metrics & Rankings
Price returns through June 10, 2022. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Zosano Pharma has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 8 with negative movement. Key topics include earnings, stock split, offering, clinical trial, management. View all ZSAN news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
ZSAN Company Profile & Sector Positioning
Zosano Pharma (ZSAN) operates in the Biotechnology industry within the broader Healthcare sector.
Investors comparing ZSAN often look at related companies in the same sector, including LIPELLA PHARMS INC (LIPO), Salarius Pharmaceuticals, Inc. (SLRX), GT Biopharma Inc. (GTBP), PROTAGENIC THERAPEUTICS (PTIX), and Virax Biolabs Group Limited (VRAX). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ZSAN's relative position within its industry.